Analysis of Borosilicate Catalysts by Inductively Coupled Plasma Atomic Emission Spectroscopy

Abstract

A method was developed for the analysis of borosilicate catalysts. Samples were prepared by fusion technique with potassium hydroxide and analyzed by inductively coupled plasma atomic emission spectroscopy (ICP-AES). The method was applied to a borosilicate NIST SRM 93 which was analyzed for major and minor elements (aluminum, sodium, silicon and boron). Despite the presence of relatively high concentration of the potassium, no matrix interferences were observed. This method provides precision and accuracy better than ±4% and ±6%, respectively.     

Development and evaluation of a monolithic floating drug delivery system for acyclovir

Acyclovir (ACV), a model drug for this study, is one of the most effective drugs against viruses of the herpes group. Absorption of orally administered ACV is variable and incomplete, with a bioavailability of ca. 15-30%. The drug is absorbed in the duodenum after oral administration and hence, preparation of a floating drug delivery system (FDDS) for ACV may increase oral absorption of the drug. ACV matrix tablets (200?mg) containing an effervescent base (sodium bicarbonate and citric acid) and a binary combination of hydroxypropyl methylcellulose (HPMC) K4M with carbopol or sodium carboxymethyl cellulose (Na CMC) or polyvinylpyrrolidone (PVP) and/or sodium alginate were prepared by the direct compression method. The tablets were evaluated for physicochemical properties and in vitro floating ability (floating lag-time and duration), bioadhesiveness and drug release. The drug release studies were carried out in 0.1?N HCl (pH 1.2) at 37±0.5°C. At appropriate time intervals, samples were withdrawn and assayed spectrophotometrically at λ(max)=259?nm. The floating test showed tablets containing 15% effervescent base had a floating lag time of 10-30?s and a duration of floating time of 24?h. The formulations containing HPMC-PVP, HPMC-Na CMC, HPMC-carbopol, and HPMC-sodium alginate released about 60-90% of their drug content during a 12-h period. Increasing carbopol caused slower drug release. We concluded that the proposed tablets with 15% effervescent base, 20-30% HPMC, 30% Na CMC (and/or 20% PVP or 20% sodium alginate) showed good floating and drug release properties in vitro, and should be considered as FDDS for ACV.     

A Validated and Stability-Indicating LC Assay Method for Valdecoxib

A gradient reversed-phase liquid chromatographic assay was developed for the quantitative determination of the non-steroidal anti-inflammatory drug valdecoxib. The developed method was also applicable to the determination of related substances in the bulk drug. Forced degradation studies were performed on bulk valdecoxib using acid (2.0 N hydrochloric acid), base (2.0 N sodium hydroxide), oxidation (6.0% v/v hydrogen peroxide), water hydrolysis, heat (60 °C) and photolysis. Mild degradation was observed using alkaline conditions and considerable degradation observed during oxidative stress. Chromatographic separation of process-related impurities and degradation products was achieved using a 5 micron Zorbax SB-CN LC column. The mobile phase consisted of aqueous potassium dihydrogen phosphate (pH 3.0) and acetonitrile. Stressed samples were assayed using the developed LC method and determination of the mass balance accounted for 99.5%, thus indicating the suitability of this stability-indicating method. Linearity, accuracy, precision and robustness have also been evaluated.     

Quantitation of Baclofen in Tablets Using High-Performance Liquid Chromatography

Abstract

A reverse phase high-performance liquid chromatography method has been developed to quantify baclofen in tablets. The method is accurate and precise with a percent relative standard deviation of 0.52 based on 5 readings. The recovery from the synthetic mixtures was quantitative. The results were in excellent agreement with the USP-NF colorimetric method. The method can be used to test the content uniformity of the tablets. Samples which were treated with either sulfuric acid or sodium hydroxide and boiled for 10 minutes did not show new peaks in the chromatogram. Baclofen appears to be a very stable compound.     

Determination of Surface Silanols of Silica Gels and HPLC Bonded Phases

Abstract

A rapid method determining the surface silanols of silica gels and HPLC bonded phases involves a titration of silica gel with sodium hydroxide, in a medium of any of the following 10% aqueous salts: sodium chloride, sodium nitrate, sodium sulfate, potassium chloride, potassium nitrate and potassium sulfate. The silanols are quantified as m eg/g. It is possible to determine cation exchange capacity of a cation-exchanger due to an acid as an end group and surface silanols separately.     

A Novel Ultra-High Performance Liquid Chromatography Method for the Determination of Erdosteine,Related Impurities and Degradation Products in New Effervescent Tablets

A novel and automated, stability-indicating, reversed phase ultra performance liquid chromatography (UPLC) method was developed and validated for the quantitative determination of erdosteine, its known impurities and two novel degradation products in a new pharmaceutical dosage form (effervescent tablets). The chromatographic separations were performed on a Waters Acquity UPLC HSS T3, 1.8 µm (2.1 mm?×?150 mm, I.D.) stainless steel column. The mobile phase consisted of 0.1% TFA in water and methanol under gradient elution conditions, at a flow rate of 0.29 mL/min, for the assay and impurities analysis. UV detection was set at a wavelength of 238 nm. Erdosteine raw material, placebo and effervescent tablets were subjected to forced degradation. The new degradation products (labeled OX1 and OX2) were found after oxidative treatment and characterized by ultra performance liquid chromatography mass spectrometry. The validation parameters such as linearity, limit of detection (LOD) and quantification (LOQ), accuracy, precision, specificity and robustness were highly satisfactory for all analyzed compounds. LOD (0.020 and 0.011–0.385 µg/mL for erdosteine and impurities, respectively) and LOQ values show the high sensibility of the method. Specificity of the method was confirmed by testing the matrix components. The validated method demonstrated to be suitable for routine quality control purposes and for routine stability studies of erdosteine in effervescent formulations.     

Determination of Prifinium Bromide in Six Pharmaceutical Formulations by Reverse-Phase Hplc

Abstract

Prifinium bromide is an anti-cholinergic drug, available commercially in various pharmaceutical formulations such as tablets, suppositories, syrups, and ampoules. The present available analytical methods are time-consuming and range from non-aqueous titration to UV-spectrophotometry to ion-pair visible spectrophotometry. The method reported here is a fast, reliable, and stability-indicating reversed phase HPLC for prifinium bromide in its various pharmaceutical formulations. The mobile phase was 0.03 M ammonium acetate in acetonitrile: water (65:35); the pH was adjusted to 4.0 with glacial acetic acid. The column utilized was (250 mm × 4.6 mm i.d.) Supelcosil LC-8-DB (5μ) and detection was carried at 254 nm. Benzophenone was used as internal standard. The assay was applied to commercial products and the results expressed in (% label claim ± RSD) are (99-58 ± 0.36), (100.50 ± 0.40), (99-95 ± 0.70), (99. 94 ± 0.29), (100.28 ± 0.52), and (99-99 ± 0.57) for six commercial formulations. The method was tested for linearity, recovery, and specificity and was found fast, stability-indicating, and free from interferences. The method can be extended to separate     

Analysis of Thyroidal Amino Acids in Pharmaceutical Preparations. I - Reverse Phase High Pressure Liquid Chromatography Analysis of Sodium Liothyronine from Tablets

Abstract

A simple, sensitive and specific assay method was developed for the assay of sodium liothyronine (T₃Na) from tablets. Sodium liothyrorn'ne was extracted from powdered tablets with a solvent system consisting of butanol and dilute hydrochloric acid. The solvent was removed under vacuum and the residue was dissolved in ammonical methanol. An aliquot of this solution was injected on a μBondapak C₁₈ column and the elution was carried out with a mobile phase consisting of methanol:water:phosphoric acid (55:45: 0.1). The effluent was monitored by U. V. detection at 254 nm. A linear calibration curve was obtained in the range of 10 to 250 ng on column with a precision of ±4% (C. V.). The internal standard consisted of 3, 3′, 5-triiodothyronine (T3′ or RT₃). The usefulness of an alternate compound, 3, 5-diiodo-3′, 5′-dibromothyronine, which is not endogenous, was also demonstrated as an internal standard.     

氢氧化钡沉淀–碘量法对高锰酸钾和锰酸钾共存时的分别测定

采用氢氧化钡沉淀–碘量法对高锰酸钾和锰酸钾共存时的含量分别进行测定。向电解液中加入过量的饱和氢氧化钡溶液,利用锰酸钡和高锰酸钡溶度积的不同进行分离,再用碘量法分别对高锰酸钾和锰酸钾进行测定。结果表明,高锰酸钾和锰酸钾的检出限分别为0.061,0.077 g/L,测定结果的相对标准偏差分别为0.57%和0.72%(n=4),高锰酸钾的加标回收率为94.12%~95.85%。t检验结果表明,氢氧化钡沉淀–碘量法与传统方法对高锰酸钾和锰酸钾的测定结果无显著性差异。该法避免了亚铅酸钠和铬盐的毒性及滴定终点颜色不易判断等缺点,适合于高锰酸钾工业生产中主要成分的快速检测。     

UV spectrophotometry and nonaqueous determination of terbinafine hydrochloride in dosage forms.

An ultraviolet spectrophotometric and a nonaqueous volumetric method for determining terbinafine hydrochloride (TH) in pharmaceutical formulations are presented. The UV spectrophotometric procedure was developed for assay of TH in raw materials, tablets, and creams. The method was tested for linearity (0.8-2.8 micrograms/mL, r = 0.9997), recovery (102.00% for creams and 99.90% for tablets) and precision (101.3%, CV = 0.96%, n = 9, for creams; 100.25%, CV = 1.08%, n = 9, for tablets). The volumetric method involves titration of TH with 0.05M perchloric acid with crystal violet as indicator. This method was used for quantitative determination of TH in raw materials and tablets. Mean recovery and precision were, respectively, 100.41 and 101.18% (CV = 1.64%, n = 9) for TH tablets. There were no significant differences between the proposed methods and a previously described high-performance liquid chromatographic method. The UV spectrophotometric and titrimetric methods are potentially useful for a routine laboratory because of their simplicity, rapidity, and accuracy.     

Development of effervescence-assisted switchable polarity solvent homogeneous liquid-phase microextraction for the determination of permethrin and deltamethrin in water samples prior to gas chromatography–flame ionization detection

An effervescent tablet-assisted switchable polarity solvent–based homogeneous liquid-phase microextraction combined with gas chromatography with flame ionization detection has been conducted for the separation, preconcentration, and detection of permethrin and deltamethrin in the river water specimens. Triethylamine (TEA) was utilized as the switchable polarity solvent in this method. The switching process was carried out by the dissolution of an effervescent tablet including an effervescency agent (sodium carbonate) and a proton donor agent (citric acid). Changing the pH of the specimen solution enhanced the conversion of TEA into protonated triethylamine carbonate through the tablet that generated carbon dioxide bubbles in situ. Finally, the addition of sodium hydroxide changed the ionization state of TEA and separated the two phases. Influential factors in the extraction were investigated. According to optimal situations, the limit of detection and the limit of quantification were 0.16 and 0.5 μg L⁻¹ for permethrin and 0.03 and 0.1 μg L⁻¹ for deltamethrin, respectively. The preconcentration factor was 194 in river water samples and inter- and intra-day precision (relative standard deviation %; n = 5) was <5%. The extraction recovery was obtained in the range of 93.0%–97% for permethrin and deltamethrin in water samples.     

The determination of phenobarbital and diphenylhydantoin in blood by differential pulse polarography

A sensitive differential pulse polarographic assay was developed for the determination of phenobarbital or diphenylhydantoin in blood. The assay involves the selective extraction of the compound into chloroform from whole blood buffered to pH 7.0. After suitable “clean-up” of the sample, each compound is nitrated in 10% potassium nitrate in sulfuric acid at 25° for 1 h. The nitro-derivatives are extracted into ethyl acetate, and the residues are dissolved in 1 M phosphate buffer (pH 7.0) or 0.1 M sodium hydroxide for phenobarbital and diphenylhydantoin, respectively; the solutions are deoxygenated, and analyzed by differential pulse polarography. The overall recovery of phenobarbital and diphenylhydantoin from blood was 72.3% ±6.5 (s_r) and 76.7 ±2.3 (s_r) respectively. The sensitivity limit is 1–2 μg ml^-1 of blood for both compounds. A modified assay for the determination of both compounds in blood with t.l.c. separation was also developed.     

高效液相色谱法同时测定诺诺感冒片中扑尔敏、扑热息痛、盐酸伪麻黄碱的含量

 采用反相高效液相色谱法 ,在C18柱上以V(甲醇 )∶V(水 ) =2 5∶75的溶液为流动相 (内含 0 .0 5mol/L磷酸二氢钠 ) ,检测波长为 2 0 5nm ,同时分离测定诺诺感冒片中扑尔敏、扑热息痛、盐酸伪麻黄碱的含量。扑尔敏、扑热息痛和盐酸伪麻黄碱的检出限分别为 1.16mg/L ,0 .15mg/L和 1.82mg/L ,其相应的回收率分别为 98.35 % (n =5 ,RSD =1.6 0 % ) ,10 1.16 % (n =5 ,RSD =1.5 0 % )和 98.5 0 % (n =5 ,RSD =1.5 9% )。方法简便、快速 ,重现性好 ,适用于诺诺感冒片的质量检验分析。     

Difference spectrophotemetric assay of mixtures of phenylpropanolamine hydrochloride with guaifensesin or fextromethorphan hydrobromide in olid cough formulations

A difference spectrophotometric method is described for the selective assay of phenylpropanolamine hydrochloride(I) in the presence of guaifenesin(II) or dextromethorphan hydrobromide(III) without prior separation. The method is based on the spectral change upon oxidation of phenylpropanolamine to benzaldehyde by sodium metaperiodate. The difference absorption spectrum is obtained by measuring oxidized against unoxidized phenylpropanolamine. This spectrum exhibits a maximum of 251.5 nm, a minimum at 275 nm and an isosbestic point at 272.5 nm. Absorbance is linear with concentration for 25–100 μg ml^?1 phenylpropanolamine at 251.5 nm. No changes in the spectra of compounds II and III were observed when these compounds were treated with metaperiodate. Guaifenesin and dextromethorphan are assayed by measuring an aliquot of the sample solution against methanol at 281.5 nm and 286 nm, respectively. Phenylpropanolamine does not interfere at these wavelengths. Calibrations are linear over the range 25–125 μg ml^?1 for II and III. Overall recoveries (±SD, n = 5) from simulated tablets were 99.8 ± 2.6% for I and 100.5 ± 0.5% for II; from simulated capsules, the recoveries were 99.2 ± 0.4% for I and 99.6 ± 0.2% for III. The assay was succesfully applied to commercial tablets and capsules containing these compounds.     

A Stability Indicating HPLC Assay for Prednisolone Sodium Phosphate in Implantable Infusion Pumps

Abstract

A stability indicting assay for prednisolone sodium phosphate (PSP) in solutions for implantable infusion pumps was developed. PSP and its major breakdown product, prednisolone, were separated from formulation excipients by reverse phase chromatography on a phenyl-bonded phase column using an acetonitrile-phosphate buffer mobile phase. Detection was by ultraviolet absorbance at 243 mm. Recovery from a synthetic formulation was 101.0 ± 0.4% (n=6). The method was used to monitor the stability of PSP solutions in implantable infusion pumps maintained at 37°C over a 21 day period.     

多维元素泡腾片的研制

以多维元素为原料,加入甘露醇、甜菊糖甙、柠檬酸和碳酸氢钠等辅料,采用湿法制粒压片,制备多维元素泡腾片,通过筛选处方和优化工艺,确定了产品的制作工艺条件及配方。结果表明,该工艺与配方为:按占片质量的比例计,甘露醇填充剂66%,柠檬酸11.3%、碳酸氢钠8.7%作崩解剂,甜菊糖甙2%、粉末香精为矫味剂0.5%、聚乙二醇6000为润滑剂2%。制备的多维元素泡腾片崩解迅速、口感良好、服用方便。     

Quantitative Estimation of Dehydroascorbic Acid and Ascorbic Acid by High-Performance Liquid Chromatography—Application to Human Milk,Plasma, and Leukocytes

Abstract

A ‘high-performance’ liquid chromatographic (HPLC) method for quantitation of dehydroascorbic acid and ascorbic acid and its application to protein-free human milk, blood plasma and leukocytes (buffy layer) is described. In the method, DL-homocysteine was used to convert dehydroascorbic acid quantitatively to ascorbic acid that was measured by reversed phase liquid chromatography. Fresh human milk was found to contain ascorbic acid 54.3±6.5 mg/1 (mean±SEM; n=4) and dehydroascorbic acid 21. 0±9.1 mg/1 (mean±SEM, n=4) when stored at +4°C. The concentration of both forms of ascorbic acid was found to detoriate in similar ratios during storage at +4°C, and pasteurization considerably increased the loss of vitamin C. After pasteurization the milk contained ascorbic acid 8.6±3.4 mg/1 (mean±SEM, n=4) and dehydroascorbic acid 6.6±2.4 mg/1 (mean±SEM, n=4). In plasma the dehydroascorbic acid content (0.16±0.03 mg/1, mean±SEM, n=23) was lower than that of ascorbic acid (9.96±0.75 mg/1, mean±SEM, n=23).

The ascorbic acid concentration in the leukocyte mixtures was 0.21±0.04 mg/10⁹ cells (mean±SEM, n=10) and dehydroascorbic acid concentration 0.09±0.03 mg/10⁹ cells (mean±SEM, n=8). A statistically significant (r=0.599, p<0.05) correlation was established between the concentrations of ascorbic acid in plasma and leukocytes.     

黄钠铁矾中铁的测定

准确快速测定黄钠铁矾中铁的含量有利于控制铁湿法冶金的流程。采用氢氧化钠溶液分解试样,盐酸(1+9)溶解滤渣,蒸发除过量酸,氨水沉淀分离铜、镍、钴等元素,再用稀盐酸溶解沉淀。在盐酸介质中,SnCl_2将大部分Fe(Ⅲ)还原为Fe(Ⅱ),钨酸钠为指示剂,用TiCl_3还原呈钨蓝色,重铬酸钾滴定至蓝色褪去。再以二苯胺磺酸钠为指示剂,重铬酸钾标准溶液滴定测定样品中铁的含量。实验表明,黄钠铁矾中共存干扰元素绝大部分被分离,同时与酸溶解法进行比较,测定数据一致,相对标准偏差(n=9)小于0.1%。     

Assay of mixtures of chlorpheniramine maleate,pyrilamine meleate and phenylpropanolamine hydrochloride in cold-allergy tablets by difference spectrophotometry

Mixtures of chlorpheniramine maleate (CPM) and phenylpropanolamine hydrochloride (PPA), with and without pyrilamine maleate (PRM), are assayed by u.v. difference spectrophotometry without prior separation. The spectra for CPM and PRM in solutions at pH 1 and pH 6 show differences whereas the spectra for PPA remain the same at pH 1 and 6. For PPA, quantitation is based on the spectral change on oxidation to benzaldehyde with metaperiodate; this oxidation does not affect CPM and PRM. Calibration plots are linear for 6.7–99.9 μg ml^?1 CPM (r = 0.9992), 12.7–50.6 μg ml^?1 PRM (r = 0.9997) and 25–115.3 μg ml^?1 PPA (r = 0.9980) in the presence of one another. Average recoveries (± RSD) from simulated PPA/CPM tablets were: PPA, 98.4 ± 0.4% (without PRM, n = 3), 99.8 ± 0.4% (with PRM, n = 5); CPM, 99.3 ± 0.6% (without PRM, n = 3), 99.2 ± 0.4% (with PRM, n = 5); and PRM, 99.5 ± 0.2% (in PPA/CPM/PRM tablets, n = 5). The method was successfully applied to commercial cold-allergy tablets containing these compounds.     

Use of Ethoxy-Homologs as Internal Standards for Determination of Urinary Vanillylmandelic Acid and Normetanephrine in Man by High Performance Liquid Chromatography

Abstract

Synthesis of the ethoxy-homologs of vanillylmandelic acid (3-ethoxy-4-hydroxymandelic acid, EMA) and normetanephrine (3-ethoxy-4-hydroxyphenylethanolamine, EHPEA) and their use in minor modifications of existing assays on human urine are described. For analysis of vanillylmandelic acid, the homologous internal standard is added to an aliquot of urine, organic acids are then extracted into ethyl acetate and back extracted into 10% K₂CO₃, and finally extracted a second time into ethyl acetate. After evaporation of the ethyl acetate, the residue is redissolved in the mobile phase to be used in the chromatography, and injected onto a reverse phase column. Comparison of results with a gas chromatography-mass spectrometry (GCMS) assay gave almost identical results (96% ± 2%, mean ± SE, n=10). Analysis of normetanephrine is performed by addition of internal standard to an aliquot of urine before heat hydrolysis of amine conjugates. The amines are adsorbed onto columns of Bio Rex 70, and then eluted with a solution of 1 M NH₄OH, which is then evaporated to dryness. After residue is redissolved in borate buffer, the amines are extracted into toluene:isoamyl alcohol and back extracted into 0.1 M acetic acid before injection onto a reverse phase column. Correlation with a GCMS assay gave similar results (102% ± 4%, mean ± SE, n=9).